Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction (LIBerate-HR)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04806893 |
Recruitment Status :
Active, not recruiting
First Posted : March 19, 2021
Last Update Posted : December 11, 2023
|
Sponsor:
LIB Therapeutics LLC
Collaborator:
Medpace, Inc.
Information provided by (Responsible Party):
LIB Therapeutics LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | November 15, 2023 |
Estimated Study Completion Date : | February 28, 2024 |